We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
-12.28%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$334B
AUM Growth
-$65.4B
Cap. Flow
-$11.7B
Cap. Flow %
-3.51%
Top 10 Hldgs %
13.97%
Holding
7,016
New
146
Increased
2,663
Reduced
3,412
Closed
209

Sector Composition

Rank Sector Weight
1 Technology 12.53%
2 Healthcare 10.36%
3 Financials 9.14%
4 Consumer Discretionary 7.65%
5 Communication Services 7.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LSXMB
6576
DELISTED
Liberty Media Corporation Series B Liberty SiriusXM Common Stock
LSXMB
$0 ﹤0.01%
12
DYNT
6577
DELISTED
Dynatronics Corp
DYNT
0
DMTK
6578
DELISTED
DermTech, Inc. Common Stock
DMTK
$0 ﹤0.01%
+1
New +$20
ISUN
6579
DELISTED
iSun, Inc. Common Stock
ISUN
$0 ﹤0.01%
1
AVGR
6580
DELISTED
Avinger, Inc. Common Stock
AVGR
-2
Closed -$3.33K
ENG
6581
DELISTED
ENGlobal Corp
ENG
-3
Closed
OPGN
6582
DELISTED
OpGen, Inc
OPGN
0
NBSE
6583
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$0 ﹤0.01%
12
-2
-14% -$145
YTEN
6584
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
0
GGE
6585
DELISTED
Green Giant Inc. Common Stock
GGE
$0 ﹤0.01%
2
-6,828
-100% -$16.9K
FGH
6586
DELISTED
FG Group Holdings Inc.
FGH
$0 ﹤0.01%
41
-1,015
-96% -$3.08K
BPTH
6587
DELISTED
Bio-Path Holdings Inc
BPTH
0
SUNW
6588
DELISTED
Sunworks, Inc.
SUNW
$0 ﹤0.01%
1
-1
-50% -$3
RPT.PRD
6589
DELISTED
RPT Realty 7.25% Series D Cumulative Convertible Perpetual Preferred Shares of Beneficial Interest
RPT.PRD
-19
Closed -$1K
SOFO
6590
DELISTED
Sonic Foundry, Inc. Common Stock
SOFO
-1
Closed
CYTO
6591
DELISTED
Altamira Therapeutics Ltd
CYTO
-32
Closed -$164K
LTRPB
6592
DELISTED
Liberty TripAdvisor Holdings, Inc. Series B
LTRPB
$0 ﹤0.01%
24
BRQS
6593
DELISTED
Borqs Technologies, Inc. Ordinary Shares
BRQS
-2
Closed -$1K
LOV
6594
DELISTED
Spark Networks SE American Depositary Shares
LOV
$0 ﹤0.01%
25
BNGOW
6595
DELISTED
Bionano Genomics, Inc. Warrant
BNGOW
$0 ﹤0.01%
300
MSVB
6596
DELISTED
Mid-Southern Bancorp, Inc.
MSVB
$0 ﹤0.01%
23
BBIG
6597
DELISTED
Vinco Ventures, Inc. Common Stock
BBIG
$0 ﹤0.01%
1
-4
-80% -$330
HVBC
6598
DELISTED
HV Bancorp, Inc. Common Stock
HVBC
$0 ﹤0.01%
1
UNAM
6599
DELISTED
Unico American Corp
UNAM
$0 ﹤0.01%
34
-128
-79% -$825
KSPN
6600
DELISTED
Kaspien Holdings Inc. Common Stock
KSPN
$0 ﹤0.01%
1

Similar funds

Morgan Stanley's Q4 2018 Portfolio in Review

As of Q4 2018, Morgan Stanley held 7,016 positions worth $334B, down 16% from $400B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Morgan Stanley withdrew a net $11.7B in Q4 2018, closing 209 positions and reducing 3,412 holdings. Its most notable exit was Praxair Inc, an estimated $398M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Morgan Stanley opened a new position in Linde worth $342M.

  • Morgan Stanley's largest Q4 2018 buy was Linde: 2,188,871 shares worth $342M.
  • Morgan Stanley added most to People Inc in Q4 2018, an estimated $558M increase.
  • Morgan Stanley's biggest Q4 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
  • Morgan Stanley fully exited Praxair Inc in Q4 2018, selling an estimated $398M.
  • Morgan Stanley's ten largest holdings make up 14% of its $334B portfolio in Q4 2018.
  • Morgan Stanley opened 146 new positions and closed 209 in Q4 2018.
  • Morgan Stanley's portfolio value fell 16% quarter-over-quarter to $334B.

Based on Morgan Stanley's 13F filing for Q4 2018, filed 14 Feb 2019.